Uppsala Reports editor
@UMCGlobalSafety
Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.
With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.
In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Uppsala Reports editor
@UMCGlobalSafety
What if risk management began earlier? DRMPs serve as a framework for safety thinking in clinical development and support better benefit–risk decision-making.
04 March 2026
UMC is at the heart of a concerted effort to develop a panacea for a global headache: How to describe medicines consistently.
21 May 2026
Safety systems do not need to be complex to be effective. Shanthi Pal explains the thinking behind the Global Smart Pharmacovigilance Strategy, and how it can be implemented.
17 December 2025